Evaluation of Ceftriaxone Utilization in Three Regional Referral Hospitals in Uganda: A Prospective Multicentre Study
Edson Ireeta Munanura, Margaret Ndagire, Bruhan Kaggwa, Helen Byomire Ndagije, Diana Nakitto Kesi, Allan Serwanga, Kalidi Rajab, Paul Kutyabami, Caroline Kazinga · 2026
Read Evaluation of Ceftriaxone Utilization in Three Regional Referral Hospitals in Uganda: A Prospective Multicentre Study by Edson Ireeta Munanura, Margaret Ndagire, Bruhan Kaggwa, Helen Byomire Ndagije, Diana Nakitto Kesi, Allan Serwanga, Kalidi Rajab, Paul Kutyabami, Caroline Kazinga (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13262674.txt.
Description
Edson Munanura and colleagues audit how three Ugandan referral hospitals use a workhorse antibiotic. Ceftriaxone treats infections and guards surgical patients, but misuse breeds resistance. Their 2026 study reviews seven hundred fifty-three patients across the three hospitals, plus talks with staff.
About two-thirds of use matched national rules, mostly as surgical prevention in once-daily doses. Blood cultures, the test that should steer therapy, happened in barely one percent of cases. Long treatment courses hurt fit, while surgery wards helped it. Staff blamed missing limits, stockouts, crushing workloads, and patchy checking. A national use plan is the authors' call.
Catalog record
| CREATOR | Edson Ireeta Munanura, Margaret Ndagire, Bruhan Kaggwa, Helen Byomire Ndagije, Diana Nakitto Kesi, Allan Serwanga, Kalidi Rajab, Paul Kutyabami, Caroline Kazinga |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |